User profiles for Bruce Neal
Bruce NealUNSW Sydney, Imperial College London,The George Institute for Global Health,University of … Verified email at georgeinstitute.org.au Cited by 161596 |
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for …
…, M Boussinesq, M Brauer, P Brooks, NG Bruce… - The lancet, 2012 - thelancet.com
Background Quantification of the disease burden caused by different risks informs
prevention by providing an account of health loss different to that provided by a disease-by-disease …
prevention by providing an account of health loss different to that provided by a disease-by-disease …
[HTML][HTML] Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
…, JR Nansseu, G Natarajan, J Nazari, B Neal… - The lancet, 2020 - thelancet.com
Background Health system planning requires careful assessment of chronic kidney disease
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-…
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-…
[HTML][HTML] Canagliflozin and cardiovascular and renal events in type 2 diabetes
B Neal, V Perkovic, KW Mahaffey… - … England Journal of …, 2017 - Mass Medical Soc
Background Canagliflozin is a sodium–glucose cotransporter 2 inhibitor that reduces glycemia
as well as blood pressure, body weight, and albuminuria in people with diabetes. We …
as well as blood pressure, body weight, and albuminuria in people with diabetes. We …
Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are
the leading cause of global mortality and a major contributor to disability. This paper reviews …
the leading cause of global mortality and a major contributor to disability. This paper reviews …
[HTML][HTML] Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
Background Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few
effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–…
effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–…
Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015
Background : The burden of cardiovascular diseases (CVDs) remains unclear in many regions
of the world. Objectives : The GBD (Global Burden of Disease) 2015 study integrated data …
of the world. Objectives : The GBD (Global Burden of Disease) 2015 study integrated data …
[HTML][HTML] Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990 …
…, AH Mokdad, M Moradi-Lakeh, M Naghavi, B Neal… - The lancet, 2016 - thelancet.com
Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides
an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden …
an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden …
Edmund Dunstan
1 Patel A; ADVANCE Collaborative Group. Effect of a fixed combination of perindopril and
indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes …
indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes …
[HTML][HTML] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a …
Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …
Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015
Importance Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying
the levels of SBP is important to guide prevention policies and interventions. Objective To …
the levels of SBP is important to guide prevention policies and interventions. Objective To …